
VERAXA BIOTECH HOLDING AG
VRXA · NASDAQ
Updated at 2026-10-15 09:07:44
- Today's High
- $1.20
- Today’s Low
- $1.08
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $1.20
- Previous Close
- $1.11
- Volume
- 62.52K
- Market Cap
- $163.98M
- P/E Ratio
- --
- EPS
- --
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- IM NEUENHEIMER FELD 584, HEIDELBERG, GERMANY, 69120
- Country
- CH
- Listing Date
- 2026-06-11
- Fiscal Year End
- December
- Shares Outstanding
- 141.41M
- CIK
- --
- Website
- --
Veraxa Biotech AG is an innovative biotechnology company dedicated to developing transformative therapeutic solutions that address critical medical needs. By leveraging advanced biotechnological platforms, Veraxa is advancing a promising pipeline of novel drug candidates across multiple therapeutic areas. The firm is committed to scientific excellence and its strategic vision focuses on creating proprietary technologies aimed at delivering breakthrough treatments, thereby enhancing patient care globally. As it moves through key clinical development stages, Veraxa is strategically positioned to attract partnerships and investments to bolster its growth in the evolving biotech sector.
Financial Metrics
--
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.